Home > Healthcare > Biotechnology > Biopharma > nucleotides market
Get a free sample of Nucleotides Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Nucleotides Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The nucleotides industry is characterized by the presence of several key players adopting technological advancements, research and development activities, and strategic initiatives:Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., and Agilent Technologies account for significant market share in the overall nucleotides market. They employ nucleotides in several applications such as pharmaceuticals, diagnostics, and biotechnology.
Market players operating in the nucleotides market are as mentioned below:
Agilent Technologies, F. Hoffmann-La Roche Ltd. (CustomBiotech), CJ CHEILJEDANG CORP., DAESANG, Jena Bioscience GmbH, MEIHUA HOLDINGS GROUP CO. LTD, Promega Corporation, and STAR LAKE BIOSCIENCE are some of the major nucleotides companies worldwide.
North America nucleotides industry is expected to reach USD 420.2 million in revenue by 2032 due to the presence of leading biotechnology and pharmaceutical companies along with the availability of robust research infrastructure in the region.
Nucleotides industry size from the diagnostic research segment recorded USD 382.4 million in 2022 and is expected to register appreciable CAGR from 2023-2032 owing to the ongoing advancements in nucleotide-based technologies.
Nucleotides industry size was USD 588.4 million in 2022 and is expected to reach USD 1.1 billion by 2032 due to the rising demand for nucleotide-based therapeutics and increased research in genomics and molecular biology worldwide.